JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/20.06.25 Stock

Warrant

DE000JK4TTN1

Real-time Bid/Ask 04:43:27 2024-06-13 am EDT
0.018 EUR / 0.068 EUR +104.76% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/160/0.1/20.06.25
Current month+16.67%
1 month-38.24%
Date Price Change
24-06-13 0.018 -14.29%
24-06-12 0.021 -32.26%
24-06-11 0.031 -6.06%
24-06-10 0.033 +106.25%
24-06-07 0.016 +23.08%

Delayed Quote Börse Stuttgart

Last update June 13, 2024 at 04:29 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JK4TTN
ISINDE000JK4TTN1
Date issued 2024-03-15
Strike 160 $
Maturity 2025-06-20 (373 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.19
Lowest since issue 0.011
Spread 0.05
Spread %73.53%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.4 USD
Average target price
125.4 USD
Spread / Average Target
+20.11%
Consensus